TRPC1 protects dopaminergic SH-SY5Y cells from MPP＋, salsolinol, and N-methyl-（R）-salsolinol-induced cytotoxicity

Neurotoxins and alterations in Ca2＋ homeostasis have been associated with Parkinson＇s disease （PD）, but the role of store-operated Ca2＋ entry channels is not well understood. Previous studies have shown the neurotoxicity of salsolinol and 1-methyl-4-phenylpyridinium ion on SH-SY5Y cells and cytoprotection induced by transient receptor potential protein 1 （TRPC1）. In the present study, N-methyl-（R）-salsolinol was tested for its cellular toxicity and effects on TRPC1 expression. MTT （3-（4,5-dimethylthiazol-2-yl）-2,5-dipbenyl- tetrazolium bromide） assays, DAPI （4＇,6-diamidino-2-pheny- lindole）, fluorescein isothiocyanate-Annexin-V/propidium iodide, western blot analysis, and JC-1 labeling revealed that the three indicated drugs could induce caspase-dependent, mitochondrial-mediated apoptosis. Exposure of SH-SY5Y cells to the indicated drugs resulted in a significant decrease in thapsigargin-mediated Ca2＋ influx and TRPC1 expression. Immnnocytochemistry experiments revealed that neurotoxins treatment induced TRPC1 translocation to the cytoplasm. Taken together, our results indicate that treatment with neurotoxins may alter Ca2＋ homeostasis and induce mitochondrial-mediated caspase-dependent cytotoxicity, an important characteristic of PD.